Successful completion of Institutional Entitlement Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Somnomed
- Accelerated non-renounceable entitlement offer
- ASX Market Release - Trading Halt
- Revenue growth up 45% in Q2
- Good revenue growth for the quarter
- Strong Q4 growth to finish transitional year
Later from Somnomed
- Retail Entitlement Offer Information Booklet
- Trading Update
- SomnoMed posts 30% revenue growth for FY2018
- Full year results and the consolidation of RSS operations
- Strong first quarter in Core business diluted by RSS results
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed